Non-invasive markers of hepatic fibrosis in patients co-infected with HCV and HIV: Comparison of the APRI and FIB-4 index

Clinica Chimica Acta

Volumn 397, Issue 1-2, 2008, Pages 51-54

  Trang, Tony ^a   Petersen, John R ^a   Snyder, Ned ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Alanine aminotransferase; Aspartate aminotransferase; Fibrosis; Hepatitis C; Human immunodeficiency virus (HIV); Platelets

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; ARTICLE; COMPARATIVE STUDY; DISEASE MARKER; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUPERINFECTION;

BIOLOGICAL MARKERS; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 51249119841     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.07.009     Document Type: Article

References (27)

1. Chen S.L., and Morgan M.R. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci 3 (2006) 47-52
2. National Institutes of Health Consensus Development Conference Statement. Management of hepatitis C 2002. Gastroenterology 123 (2002) 2082-2099
3. Saillour F., Dabis F., Dupon M., et al. Prevalence and determinants of antibodies to hepatitis C virus and markers for hepatitis B virus infection in patients with HIV infection in Aqutaine. BMJ 313 (1996) 461-464
4. Sherman K.E., Rouster S.D., Chung R.T., and Rajicic N. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US Adult AIDS Clinical Trials Group. Clin Infect Dis 34 (2002) 831-837
5. Rosenthal E., Poiree M., Pradier C., et al. Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study). AIDS 17 (2003) 1803-1809
6. Giordano T.P., Kramer J.R., Souchek J., Richardson P., and El-Serag H. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study,1992-2001. Arch Intern Med 164 (2004) 2349-2354
7. Palella F.J., Delaney K.M., Moorman A.C., Loveless M.O., Fuher J., and Satten G.A. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338 (1998) 853-860
8. Martin-Carbonero L., Benhamou Y., Puoti M., et al. Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study. Clin Infect Dis 38 (2004) 128-1332
9. Graham C.S., Baden J.R., Yu E., Mrus J.M., Carnie J Heeren T., and Koziel M.J. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis 33 (2001) 562-569
10. Soto B., Sanchez-Quijano A., Rodrigo L., Angel del Olmo J., Garcia-Bengoechea M., and Hernandez-Quero J. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 26 (1997) 1-5
11. Martinez-Sierra C., Arizcorreta A., Diaz F., et al. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C and human immunodeficiency virus. Clin Infect Dis 36 (2003) 491-498
12. Brau N. Chronic hepatitis C in patients with HIV/AIDS: a new challenge in antiviral therapy. J Antimicrob Chemother 56 (2005) 991-995
13. Strader D.B., Wright T., Thomas D., and Seeff L.B. Diagnosis, management, and treatment of hepatitis C. Hepatology 39 (2004) 1147-1171
14. Torriani F.J., Rodriguez-Torres M., Rockstroh J.K., et al. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection HIV-infected patients. N Engl J Med 351 (2004) 438-450
15. Sterling R.K. Role of liver biopsy in the evaluation of hepatitis C virus infection in HIV coinfection. Clin Infect Dis 40 (2005) S270-275
16. Regev A., Berho M., Jeffers L.J., et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97 (2002) 2614-2618
17. Bedossa P., Dargere D., and Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38 (2003) 1449-1457
18. Wai C.T., Greenson J.K., Fontana R.J., et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38 (2003) 518-526
19. Snyder N., Gajula L., Xiao S.Y., et al. APRI: An easy and validated predictor of hepatic fibrosis in chronic hepatitis C. J Clin Gastroenterol 40 (2006) 535-542
20. Nunes D., Fleming C., Offner G., et al. HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease. J Acquir Immune Defic Syndr 40 (2005) 538-544
21. Al-Mohri H., Copper C., Murphy T., and Klein M.B. Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients. HIV Medicine 6 (2005) 375-378
22. Shastry L., Wilson T., Lascher S., and Nord J.A. The utility of aspartate aminotransferase/platelet ratio index in HIV/hepatitis C co-infected patients. AIDS 21 (2007) 2541-2543
23. Sterling R.K., Lissen E., Clumeck N., Sola R., Correa M.C., Montaner J., et al. Development of a simple non-invasive index to predict significant fibrosis in patients with HIV/HCV co-infection. Hepatology 43 (2006) 1317-1325
24. Batts K.P., and Ludwig J. Chronic hepatitis; an update on terminology and reporting. Am J Surg Pathol 19 (1995) 1409-1417
25. Carvello-Filho R.J., Schiamon L.L., Narciso-Schiamon J.L., et al. Optimizing cutoffs improve performance of the aspartate aminotransferase tp platelet ratio index in predicting significant fibrosis in human immunodeficiency virus/ hepatitis C virus infection. Liver International 28 (2008) 486-493
26. Vallet-Pichard A., Mallet V., Nalpas B., et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology 32 (2007) 32-36
27. Snyder N., Nguyen A., Gajula L., et al. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C. Clin Chem Acta 381 (2007) 119-123